AstraZeneca on Monday became the second company in recent weeks to announce it will cap the out-of-pocket costs that patients pay for its inhalers at $35. The cap is effective June 1 and will apply to ...
One of the top inhaler manufacturers in the U.S. announced plans on Thursday to cap the out-of-pocket cost of all its inhalers at $35 a month starting later this year after facing Democratic ire.
In an effort to plant a talking point in the next Republican presidential debate prevent damage to the ozone layer, the Obama administration will order the phase-out of an over-the-counter asthma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback